EUVIMEDEUVIMED entdecken
Crossref

Application of Phosphoramidate ProTide Technology for the Synthesis of 5’‐mRNA Cap Analogs Modified on the Exocyclic Amine Group

Izabela Siekierska, Maciej Lukaszewicz, Remigiusz Worch, Marzena Jankowska-Anyszka, Karolina Piecyk iD

ChemMedChem · 2023

DOI: 10.1002/cmdc.202200490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von Izabela Siekierska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, University of Warsaw, 1 Pasteur St., 02-093, Warsaw, Poland. Hauptthemen laut MEDLINE: Antiviral Agents, Prodrugs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aryloxy triester phosphoramidate methodology, commonly known as ProTide technology, is one of the most widely used prodrug approaches applied to therapeutic nucleosides. This approach has been used extensively by the pharmaceutical industry and researchers in medicinal chemistry. Herein we report our adaptation of this effective method for the synthesis of bioactive 5’‐mRNA cap analogues as inhibitors for targeting cap‐dependent translation. The synthesis was performed in two main stages: preparation of N2‐modified guanosine analogues and their subsequent transformation into prodrugs using phenylethoxy‐ l ‐alaninyl phosphorochloridate. The prepared pro‐nucleotide cap analogues were tested for their capacity in enzymatic activation, inhibitory properties in a rabbit reticulocyte lysate system, and passive membrane translocation properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsProdrugsAnimalsRabbitsRNA, MessengerTechnologyAminesAmidesPhosphoric Acids

Stichwörter der Autor:innen

N2-guanosine modificationcap analogsmRNAphosphoramidate (ProTide) approach

Substanzen

Antiviral AgentsRNA, MessengerAminesProdrugsphosphoramidic acidAmidesPhosphoric Acids

Autor:innen und Institutionen

  • Faculty of Chemistry, University of Warsaw, 1 Pasteur St., 02-093, Warsaw, Poland.
  • Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, 02-089, Warsaw, Poland.
  • Nencki Institute of Experimental Biology, 3 Pasteur Street, 02-093, Warsaw, Poland.

ORCID-Profile: Karolina Piecyk

Zitieren

APA

Siekierska, I., Lukaszewicz, M., Worch, R., Jankowska-Anyszka, M., & Piecyk, K. (2023). Application of Phosphoramidate ProTide Technology for the Synthesis of 5’‐mRNA Cap Analogs Modified on the Exocyclic Amine Group. ChemMedChem. https://doi.org/10.1002/cmdc.202200490

Vancouver

Siekierska I, Lukaszewicz M, Worch R, Jankowska-Anyszka M, Piecyk K. Application of Phosphoramidate ProTide Technology for the Synthesis of 5’‐mRNA Cap Analogs Modified on the Exocyclic Amine Group. ChemMedChem. 2023. doi:10.1002/cmdc.202200490

BibTeX
@article{Siekierska2023,
  author = {Siekierska, Izabela and Lukaszewicz, Maciej and Worch, Remigiusz and Jankowska-Anyszka, Marzena and Piecyk, Karolina},
  title = {Application of Phosphoramidate ProTide Technology for the Synthesis of 5’‐mRNA Cap Analogs Modified on the Exocyclic Amine Group},
  journal = {ChemMedChem},
  year = {2023},
  doi = {10.1002/cmdc.202200490}
}
Kostenlos starten →